Results 231 to 240 of about 3,222,626 (259)

Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing. [PDF]

BMC Prim Care
Devine B, Aalbers SE, Chan H, Jiang S, Dusic EJ, Knerr S, Harris HM, Wang C, Norquist BM, Riemann LA, Brant JM, Shirts BH, Swisher EM.   +12 more
europepmc   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Psychosocial predictors of hereditary cancer genetic testing motivation in untested individuals. [PDF]

J Genet Couns
Austin S, Delacroix E, Rice JD, Koeppe E, Stoffel EM, Griggs JJ, Resnicow K.   +6 more
europepmc   +1 more source

Predictors of Genetic Testing for Hereditary Cancer in Qualified Individuals. [PDF]

Med Res Arch
Arida-Moody L, Austin S, Hanson EN, Delacroix E, Koeppe E, Rice JD, Demerath M, Weiner S, Griggs JJ, Resnicow K, Stoffel EM.   +10 more
europepmc   +1 more source

Why Hereditas leads hereditary cancer awareness now more than ever. [PDF]

Hereditas
Kazi JU, Massoumi R.
europepmc   +1 more source

Quality of life, anxiety and cancer worry following hereditary cancer testing: a 6-month Swedish follow-up study. [PDF]

Qual Life Res
Heyman Y, Röjlar H, Hawranek C, Numan Hellquist B, Rosén A.   +4 more
europepmc   +1 more source

Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review. [PDF]

Int J Gynecol Cancer
Beshar I, Agusti N, Barajas K, Krause K, Nitecki Wilke R, Rauh-Hain JA.   +5 more
europepmc   +1 more source

Prevalence of MUTYH Monoallelic Variants in Patients With Hereditary Cancer Using Multigene Panel Testing. [PDF]

Cancer Med
Caliendo G, Della Pepa C, Mignano A, Albanese L, Passariello L, Cozzolino A, Iengo F, Molinari AM, Pesce L, Vietri MT.   +9 more
europepmc   +1 more source

Incomplete Family History and Meeting Algorithmic Criteria for Genetic Evaluation of Hereditary Cancer.

JAMA Netw Open
Harris A, Bather JR, Bradshaw RL, Kawamoto K, Del Fiol G, Kohlmann WK, Chavez-Yenter D, Monahan R, Chambers RL, Sigireddi M, Goodman MS, Kaphingst KA.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genetic testing in prostate cancer management: Considerations informing primary care

Ca-A Cancer Journal for Clinicians, 2022
Mary-Ellen Taplin, Veda Giri, Jacob Berchuck   +2 more
exaly